their service providers, supports
clinical trials of all sizes, from single site studies to multi-national
programs. The TrialWorks solution provides comprehensive trial management
data for the entire clinical team, from consolidated metrics for senior
management to reports for project teams. It delivers relevant information
to all study stakeholders, promotes operational and workflow standards, and
helps to ensure timely investigator payments as well as accurate financial
reporting. The system also provides online and offline access to clinical
monitors.
New enhancements to the TrialWorks solution include:
-- "My Reports" - with over 175 standard reports tailored for key
departments and an ad-hoc reporting component, this feature now allows
users and project teams to more easily access and share frequently used
reports, saving time and creating a more organized reporting environment
-- Compatibility with new requirements of the ClinicalTrials.gov
website, and ability to export files for import into ClinicalTrials.gov
-- New options to classify studies, offering greater flexibility in
grouping studies together, as well as enhancements for more detailed
filtering and analysis of study information
Additionally, a new web interface for the Universal Data Transfer Tool,
which can be used in conjunction with the TrialWorks solution, provides a
more streamlined transfer of patient and visit data as well as Case Report
Form (CRF) status from other systems.
The TrialWorks solution, previously part of the ClinPhone product
portfolio, has been used for thousands of clinical trials. The system,
which has a user-friendly and intuitive interface, can be rapidly
implemented company-wide. The TrialWorks solution can be licensed and
installed, or implemented as a hosted solution.
About Perceptive Informatics
Perceptive Informatics, a subsidiary of PAREXEL, is one of the
industry's leading eClinical technology providers. Percep
'/>"/>
SOURCE PAREXEL International Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine technology :1.
Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study2.
First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival3.
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer4.
TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil5.
New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies6.
Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting7.
Tailored Clopidogrel Dosing Improves PCI Outcomes8.
Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder9.
SuperGens DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine10.
Gene Therapy Improves Vision in Patients with Congenital Retinal Disease11.
Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents